+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Neurosurgical Products - Medical Devices Pipeline Assessment, 2020

  • ID: 5230861
  • Report
  • December 2020
  • Region: Global
  • 131 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

FEATURED COMPANIES

  • Alcyone Lifesciences Inc
  • Cartosense Pvt Ltd
  • InVivo Therapeutics Corp
  • Kuros Biosciences AG
  • Nanonerve Inc.
  • Skull Base Institute
  • MORE
Summary

The publisher's Medical Devices sector report, “Neurosurgical Products - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Neurosurgical Products pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Neurosurgical Products are specialized surgical devices used for performing neurosurgical procedures. Dura Substitutes, Neuroendoscopes and Neurosurgical Drills are tracked under this category.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Neurosurgical Products under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Neurosurgical Products and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Neurosurgical Products under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Alcyone Lifesciences Inc
  • Cartosense Pvt Ltd
  • InVivo Therapeutics Corp
  • Kuros Biosciences AG
  • Nanonerve Inc.
  • Skull Base Institute
  • MORE
1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 Neurosurgical Products Overview

3 Products under Development
3.1 Neurosurgical Products - Pipeline Products by Stage of Development
3.2 Neurosurgical Products - Pipeline Products by Segment
3.3 Neurosurgical Products - Pipeline Products by Territory
3.4 Neurosurgical Products - Pipeline Products by Regulatory Path
3.5 Neurosurgical Products - Pipeline Products by Estimated Approval Date
3.6 Neurosurgical Products - Ongoing Clinical Trials

4 Neurosurgical Products - Pipeline Products under Development by Companies
4.1 Neurosurgical Products Companies - Pipeline Products by Stage of Development
4.2 Neurosurgical Products - Pipeline Products by Stage of Development

5 Neurosurgical Products Companies and Product Overview
5.1 Alcyone Lifesciences Inc Company Overview
5.1.1 Alcyone Lifesciences Inc Pipeline Products & Ongoing Clinical Trials Overview
5.2 Aleva Neurotherapeutics SA Company Overview
5.2.1 Aleva Neurotherapeutics SA Pipeline Products & Ongoing Clinical Trials Overview
5.3 Augusta University Company Overview
5.3.1 Augusta University Pipeline Products & Ongoing Clinical Trials Overview
5.4 Axion BioSystems Inc Company Overview
5.4.1 Axion BioSystems Inc Pipeline Products & Ongoing Clinical Trials Overview
5.5 C2C Development, LLC Company Overview
5.5.1 C2C Development, LLC Pipeline Products & Ongoing Clinical Trials Overview
5.6 Carnegie Mellon University Company Overview
5.6.1 Carnegie Mellon University Pipeline Products & Ongoing Clinical Trials Overview
5.7 Carthera SAS Company Overview
5.7.1 Carthera SAS Pipeline Products & Ongoing Clinical Trials Overview
5.8 Cartosense Pvt Ltd Company Overview
5.8.1 Cartosense Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.9 Cizeta Surgical Company Overview
5.9.1 Cizeta Surgical Pipeline Products & Ongoing Clinical Trials Overview
5.10 Cornell University Company Overview
5.10.1 Cornell University Pipeline Products & Ongoing Clinical Trials Overview
5.11 Elite Surgical Supplies (Pty) Ltd Company Overview
5.11.1 Elite Surgical Supplies (Pty) Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.12 InSightec Ltd Company Overview
5.12.1 InSightec Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.13 Integra LifeSciences Holdings Corp Company Overview
5.13.1 Integra LifeSciences Holdings Corp Pipeline Products & Ongoing Clinical Trials Overview
5.14 International HIFU Company Overview
5.14.1 International HIFU Pipeline Products & Ongoing Clinical Trials Overview
5.15 InVivo Therapeutics Corp Company Overview
5.15.1 InVivo Therapeutics Corp Pipeline Products & Ongoing Clinical Trials Overview
5.16 JetGuide Ltd Company Overview
5.16.1 JetGuide Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.17 Johns Hopkins University Company Overview
5.17.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
5.18 KARL STORZ SE & Co KG Company Overview
5.18.1 KARL STORZ SE & Co KG Pipeline Products & Ongoing Clinical Trials Overview
5.19 Kerecis ehf Company Overview
5.19.1 Kerecis ehf Pipeline Products & Ongoing Clinical Trials Overview
5.20 Kuros Biosciences AG Company Overview
5.20.1 Kuros Biosciences AG Pipeline Products & Ongoing Clinical Trials Overview
5.21 LeMaitre Vascular Inc Company Overview
5.21.1 LeMaitre Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview
5.22 Massachusetts Institute of Technology Company Overview
5.22.1 Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview
5.23 Mayo Clinic Company Overview
5.23.1 Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview
5.24 Medtronic Navigation Inc Company Overview
5.24.1 Medtronic Navigation Inc Pipeline Products & Ongoing Clinical Trials Overview
5.25 MRC Systems GmbH Company Overview
5.25.1 MRC Systems GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.26 Nanonerve Inc. Company Overview
5.26.1 Nanonerve Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.27 Neuraptive Therapeutics Inc Company Overview
5.27.1 Neuraptive Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.28 Nurami Medical Ltd Company Overview
5.28.1 Nurami Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.29 Orthocell Ltd Company Overview
5.29.1 Orthocell Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.30 PediaWorks Inc Company Overview
5.30.1 PediaWorks Inc Pipeline Products & Ongoing Clinical Trials Overview
5.31 Replication Medical Inc Company Overview
5.31.1 Replication Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.32 Resultados y Calidad del Sistema Sanitario Publico de Andalucia Company Overview
5.32.1 Resultados y Calidad del Sistema Sanitario Publico de Andalucia Pipeline Products & Ongoing Clinical Trials Overview
5.33 Skull Base Institute Company Overview
5.33.1 Skull Base Institute Pipeline Products & Ongoing Clinical Trials Overview
5.34 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview
5.34.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview
5.35 Surgify Medical Oy Company Overview
5.35.1 Surgify Medical Oy Pipeline Products & Ongoing Clinical Trials Overview
5.36 The Swedish Neuroscience Institute Company Overview
5.36.1 The Swedish Neuroscience Institute Pipeline Products & Ongoing Clinical Trials Overview
5.37 University of Colorado Company Overview
5.37.1 University of Colorado Pipeline Products & Ongoing Clinical Trials Overview
5.38 University of Maryland Baltimore Company Overview
5.38.1 University of Maryland Baltimore Pipeline Products & Ongoing Clinical Trials Overview
5.39 University of South Florida Company Overview
5.39.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview
5.40 University of Texas Medical Branch at Galveston Company Overview
5.40.1 University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview
5.41 University of Utah Company Overview
5.41.1 University of Utah Pipeline Products & Ongoing Clinical Trials Overview
5.42 Vanderbilt University Company Overview
5.42.1 Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview
5.43 Xylos Corporation Company Overview
5.43.1 Xylos Corporation Pipeline Products & Ongoing Clinical Trials Overview

6 Neurosurgical Products- Recent Developments
6.1 Aug 21, 2020: OssDsign reports successful outcome at 6-month follow-up of clinical study on sinus augmentation
6.2 Aug 13, 2020: Renishaw: Preliminary announcement of unaudited results for the year ended 30 June 2020
6.3 Mar 02, 2020: Stryker announces new Investor Relations leader
6.4 Feb 28, 2020: Leica Microsystems announces new market representation for Mid-Atlantic medical market
6.5 Feb 26, 2020: Mayo Clinic reports 'remarkable growth' in 2019
6.6 Feb 25, 2020: Stryker announces nomination of new Director, Lisa Skeete Tatum
6.7 Feb 24, 2020: 2020 Catalyst award winner Medtronic hires Chief Inclusion and Diversity Officer
6.8 Feb 24, 2020: 2020 Catalyst Award Winner Medtronic hires Chief Inclusion and Diversity Officer
6.9 Feb 19, 2020: Integra LifeSciences reports fourth quarter and full-year 2019 financial results and provides 2020 financial guidance
6.10 Feb 19, 2020: Duke University and Leica Microsystems establish Center of Excellence in Microscopy
6.11 Feb 18, 2020: Medtronic reports third quarter financial results 2020
6.12 Feb 12, 2020: ClearPoint Neuro reports 53% increase in 2019 revenue
6.13 Feb 06, 2020: Cardinal Health reports second quarter results for fiscal year 2020
6.14 Feb 05, 2020: Stryker expands Flower Mound regional headquarters
6.15 Jan 28, 2020: Stryker reports 2019 results and 2020 outlook
6.16 Jan 24, 2020: Cardinal Health: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers
6.17 Jan 23, 2020: INSIGHTEC has received a Pre-Market Approval (PMA) for its Exablate Neuro from the Japanese Ministry of Health Labor and Welfare (MHLW).
6.18 Jan 23, 2020: Brainlab acquires San Diego-based VisionTree Software
6.19 Jan 16, 2020: Phoenix Children’s is the first-ever health system in the U.S to use Medtronic Stealth Autoguide Cranial Robotic Guidance Platform for Neurosurgery
6.20 Jan 13, 2020: Misonix reports preliminary fiscal 2020 second quarter revenue of approximately $19.7 million
6.21 Jan 13, 2020: MRI Interventions to change corporate name to ClearPoint Neuro
6.22 Dec 27, 2019: NIH awards U of U health $10 million to lead international clinical trial to evaluate treatment options for hydrocephalus in children
6.23 Dec 23, 2019: Mayo Clinic names chief digital officer to lead transformative digital strategy, create Center for Digital Health
6.24 Dec 20, 2019: Cook Medical applauds congressional action to repeal the medical device excise tax
6.25 Dec 17, 2019: Kelyniam Global announces partnership with SurgicalOne
6.26 Dec 13, 2019: Kelyniam Global releases Q3 financials
6.27 Dec 12, 2019: BRAIN AG publishes preliminary results for the financial year 2018/19
6.28 Dec 11, 2019: Tenth record-breaking year in a row for ZEISS
6.29 Dec 10, 2019: BioArctic strengthens its management team with two strategic recruitments
6.30 Dec 09, 2019: Lantheus enters into strategic collaboration with CarThera for use of microbubbles in combination with SonoCloud System for treatment of Glioblastoma
6.31 Dec 04, 2019: Lumeon and Medtronic partner to deliver new models of care in Europe
6.32 Dec 03, 2019: RTI Surgical accelerates business transformation with senior leadership appointments
6.33 Dec 03, 2019: Dr. John Halamka named president of Mayo Clinic Platform
6.34 Dec 02, 2019: Bringing Hope to Spinal Muscular Atrophy (SMA) Patients with the Alcyone Lifesciences ThecaFlex DRx™ System Breakthrough Device

7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact
7.4 Disclaimer

List of Tables
Table 1: Neurosurgical Products - Pipeline Products by Stage of Development
Table 2: Neurosurgical Products - Pipeline Products by Segment
Table 3: Neurosurgical Products - Pipeline Products by Territory
Table 4: Neurosurgical Products - Pipeline Products by Regulatory Path
Table 5: Neurosurgical Products - Pipeline Products by Estimated Approval Date
Table 6: Neurosurgical Products - Ongoing Clinical Trials
Table 7: Neurosurgical Products Companies - Pipeline Products by Stage of Development
Table 8: Neurosurgical Products - Pipeline Products by Stage of Development
Table 9: Alcyone Lifesciences Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 10: Next-Gen Chronic AMC - Product Status
Table 11: Next-Gen Chronic AMC - Product Description
Table 12: ThecaFlex DRx System - Product Status
Table 13: ThecaFlex DRx System - Product Description
Table 14: Aleva Neurotherapeutics SA Pipeline Products & Ongoing Clinical Trials Overview
Table 15: spiderSTIM - Product Status
Table 16: spiderSTIM - Product Description
Table 17: Augusta University Pipeline Products & Ongoing Clinical Trials Overview
Table 18: Surgical Instrument - Neurological Procedures - Product Status
Table 19: Surgical Instrument - Neurological Procedures - Product Description
Table 20: Axion BioSystems Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 21: Microhook Based Nerve Tape Device - Product Status
Table 22: Microhook Based Nerve Tape Device - Product Description
Table 23: C2C Development, LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 24: NAViTECH Streamlined Device - Product Status
Table 25: NAViTECH Streamlined Device - Product Description
Table 26: Carnegie Mellon University Pipeline Products & Ongoing Clinical Trials Overview
Table 27: Hydrosurgery System - Product Status
Table 28: Hydrosurgery System - Product Description
Table 29: Carthera SAS Pipeline Products & Ongoing Clinical Trials Overview
Table 30: SonoCloud - 9 - Product Status
Table 31: SonoCloud - 9 - Product Description
Table 32: SonoCloud System - Product Status
Table 33: SonoCloud System - Product Description
Table 34: SonoProbe - Product Status
Table 35: SonoProbe - Product Description
Table 36: Carthera SAS - Ongoing Clinical Trials Overview
Table 37: SonoCloud System - Safety and Efficacy of Blood Brain Barrier Opening with Implantable Device Sonocloud Combined with Nivolumab Used Alone or an Association with Ipilimumab in Brain Metastases from Patients with Malignant Melanoma
Table 38: SonoCloud - 9 - A Study to Evaluate the Safety and the Efficacy of Transient Opening of the Blood-brain Barrier (BBB) by Low Intensity Pulsed Ultrasound with the SonoCloud-9 Implantable Device in Recurrent Glioblastoma Patients Eligible for Surgery and for Carboplatin Chemotherapy
Table 39: SonoCloud - 9 - Multisite Open-label Randomized Phase II Clinical Trial in Newly Diagnosed Glioblastoma Treated by Concurrent Temoradiation and Adjuvant Temozolomide +/- Ultrasound-induced Blood Brain Barrier Opening
Table 40: Cartosense Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 41: Portable Surgical Navigation System - Product Status
Table 42: Portable Surgical Navigation System - Product Description
Table 43: Cizeta Surgical Pipeline Products & Ongoing Clinical Trials Overview
Table 44: SKULL GRIP - Product Status
Table 45: SKULL GRIP - Product Description
Table 46: Cornell University Pipeline Products & Ongoing Clinical Trials Overview
Table 47: Tightly-Focused Femtosecond Laser - Product Status
Table 48: Tightly-Focused Femtosecond Laser - Product Description
Table 49: Elite Surgical Supplies (Pty) Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 50: CRANIAL SYSTEM - Product Status

List of Figures
Figure 1: Neurosurgical Products - Pipeline Products by Stage of Development
Figure 2: Neurosurgical Products - Pipeline Products by Segment
Figure 3: Neurosurgical Products - Pipeline Products by Territory
Figure 4: Neurosurgical Products - Pipeline Products by Regulatory Path
Figure 5: Neurosurgical Products - Pipeline Products by Estimated Approval Date
Figure 6: Neurosurgical Products - Ongoing Clinical Trials
Note: Product cover images may vary from those shown
3 of 3
  • Alcyone Lifesciences Inc
  • Aleva Neurotherapeutics SA
  • Augusta University
  • Axion BioSystems Inc
  • C2C Development, LLC
  • Carnegie Mellon University
  • Carthera SAS
  • Cartosense Pvt Ltd
  • Cizeta Surgical
  • Cornell University
  • Elite Surgical Supplies (Pty) Ltd
  • InSightec Ltd
  • Integra LifeSciences Holdings Corp
  • International HIFU
  • InVivo Therapeutics Corp
  • JetGuide Ltd
  • Johns Hopkins University
  • KARL STORZ SE & Co KG
  • Kerecis ehf
  • Kuros Biosciences AG
  • LeMaitre Vascular Inc
  • Massachusetts Institute of Technology
  • Mayo Clinic
  • Medtronic Navigation Inc
  • MRC Systems GmbH
  • Nanonerve Inc.
  • Neuraptive Therapeutics Inc
  • Nurami Medical Ltd
  • Orthocell Ltd
  • PediaWorks Inc
  • Replication Medical Inc
  • Resultados y Calidad del Sistema Sanitario Publico de Andalucia
  • Skull Base Institute
  • Sree Chitra Tirunal Institute for Medical Sciences & Technology
  • Surgify Medical Oy
  • The Swedish Neuroscience Institute
  • University of Colorado
  • University of Maryland Baltimore
  • University of South Florida
  • University of Texas Medical Branch at Galveston
  • University of Utah
  • Vanderbilt University
  • Xylos Corporation
Note: Product cover images may vary from those shown
Adroll
adroll